Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > Highlights of Management Board – October 2021 meeting

https://www.ema.europa.eu/en/news/highlights-management-board-october-2021-meeting

Philippe Calandra 18 October 2021 All news
  • ← Submission of changes during the clinical trial and reporting on ongoing clinical trials
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021 →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • List of medicines under additional monitoring
  • European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure
  • European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
Copyright © 2018 - Pharmya - Legal terms - Quality Policy